Samsung Biologics Co.,Ltd. (KRX:207940)

Samsung Biologics Statistics

Total Valuation

KRX:207940 has a market cap or net worth of KRW 86.90 trillion. The enterprise value is 86.68 trillion.

Market Cap	86.90T
Enterprise Value	86.68T

Important Dates

The last earnings date was Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	n/a

Share Statistics

KRX:207940 has 46.29 million shares outstanding.

Current Share Class	46.29M
Shares Outstanding	46.29M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	12.95%
Float	11.83M

Valuation Ratios

The trailing PE ratio is 67.58 and the forward PE ratio is 45.35. KRX:207940's PEG ratio is 2.07.

PE Ratio	67.58
Forward PE	45.35
PS Ratio	17.27
PB Ratio	7.49
P/TBV Ratio	9.76
P/FCF Ratio	190.37
P/OCF Ratio	37.20
PEG Ratio	2.07

Enterprise Valuation

The stock's EV/EBITDA ratio is 37.78, with an EV/FCF ratio of 189.87.

EV / Earnings	67.41
EV / Sales	17.23
EV / EBITDA	37.78
EV / EBIT	52.69
EV / FCF	189.87

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.12.

Current Ratio	1.57
Quick Ratio	0.45
Debt / Equity	0.12
Debt / EBITDA	0.62
Debt / FCF	3.11
Interest Coverage	36.99

Financial Efficiency

Return on equity (ROE) is 11.73% and return on invested capital (ROIC) is 8.12%.

Return on Equity (ROE)	11.73%
Return on Assets (ROA)	5.96%
Return on Invested Capital (ROIC)	8.12%
Return on Capital Employed (ROCE)	11.51%
Revenue Per Employee	996.97M
Profits Per Employee	254.79M
Employee Count	4,770
Asset Turnover	0.29
Inventory Turnover	0.82

Taxes

In the past 12 months, KRX:207940 has paid 287.40 billion in taxes.

Income Tax	287.40B
Effective Tax Rate	18.27%

Stock Price Statistics

The stock price has increased by +22.35% in the last 52 weeks. The beta is 0.16, so KRX:207940's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	+22.35%
50-Day Moving Average	1,637.00
200-Day Moving Average	1,625.00
Relative Strength Index (RSI)	77.16
Average Volume (20 Days)	67,626

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:207940 had revenue of KRW 5.03 trillion and earned 1.29 trillion in profits. Earnings per share was 27,778.66.

Revenue	5.03T
Gross Profit	2.64T
Operating Income	1.63T
Pretax Income	1.57T
Net Income	1.29T
EBITDA	2.28T
EBIT	1.63T
Earnings Per Share (EPS)	27,778.66

Balance Sheet

The company has 1.64 trillion in cash and 1.42 trillion in debt, giving a net cash position of 226.81 billion or 4,899.69 per share.

Cash & Cash Equivalents	1.64T
Total Debt	1.42T
Net Cash	226.81B
Net Cash Per Share	4,899.69
Equity (Book Value)	11.60T
Book Value Per Share	250,649.29
Working Capital	2.06T

Cash Flow

In the last 12 months, operating cash flow was 2.34 trillion and capital expenditures -1,879.81 billion, giving a free cash flow of 456.50 billion.

Operating Cash Flow	2.34T
Capital Expenditures	-1,879.81B
Free Cash Flow	456.50B
FCF Per Share	9,861.62

Margins

Gross margin is 52.54%, with operating and profit margins of 32.33% and 25.56%.

Gross Margin	52.54%
Operating Margin	32.33%
Pretax Margin	31.27%
Profit Margin	25.56%
EBITDA Margin	45.23%
EBIT Margin	32.33%
FCF Margin	9.07%

Dividends & Yields

KRX:207940 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.48%
FCF Yield	0.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:207940 has an Altman Z-Score of 8.13 and a Piotroski F-Score of 7.

Altman Z-Score	8.13
Piotroski F-Score	7